Double-Blind, Placebo Controlled, Randomized Study of Vardenafil to Determine Efficacy on Erectile Dysfunction (ED) in Men With ED and Metabolic Syndrome (ED-METABOLIC).
Phase of Trial: Phase IV
Latest Information Update: 13 Jan 2014
At a glance
- Drugs Vardenafil (Primary)
- Indications Erectile dysfunction
- Focus Adverse reactions; Therapeutic Use
- Acronyms ED-METABOLIC
- Sponsors Bayer
- 21 Nov 2012 New source identifid and integrated (German Clinical Trials Register: DRKS00004131).
- 21 Apr 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2008-002140-41).
- 20 Jan 2010 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History